Saul Shiffman, Ph.D. – Founder and Chief Science Officer

Saul Shiffman – leader in development of electronic patient diariesSaul Shiffman, Ph.D., is Co-founder and Chief Science Officer for invivodata, inc. where he is responsible for advising on the scientific aspects of product development and delivery. Over the past 20 years, he has repeatedly been recognized for defining the concepts for real-time, real-world collection of PRO data – which led to the development of electronic patient diaries – as they are known today.

Dr. Shiffman is professor of psychology (clinical and health psychology), psychiatry and pharmaceutical sciences at the University of Pittsburgh, has served on various scientific panels for the National Institutes of Health, and he has served as a consultant to the pharmaceutical industry and a site investigator for more than a decade. He has authored or co-authored over 250 published papers on a variety of topics related to psychopharmacology, substance abuse, dependence, relapse, coping, and computerized assessments of behavior, and has presented widely in medical and scientific forums. With Dr. Arthur Stone, he has defined the Ecological Momentary Assessment (EMA) approach to data collection. Dr. Shiffman has edited several special sections of leading health journals on these methods. He developed the first palm-top computer solution for collecting EMA diary data. In addition to serving on scientific panels for the National Institutes of Health, he has served as a Consultant to the pharmaceutical industry and a site investigator for over a decade. In 2007, Dr. Shiffman was awarded a Lifetime Achievement Award by Good Clinical Practice Journal for these contributions. Dr. Shiffman earned his Ph.D. from UCLA.